Abstract
Background and Objectives
Subjects and Method
Results
Conclusion
Notes
Author Contribution
Conceptualization: So Jeong Kim, Jung Ho Bae. Data curation: So Jeong Lee, Yu jin Go, Sohl Park. Formal analysis: So Jeong Lee, Yu jin Go, Sohl Park. Supervision: Jung Ho Bae. Writing—original draft: So Jeong Kim. Writing—review & editing: So Jeong Kim, So Jeong Lee, Jung Ho Bae.
REFERENCES
Table 1.
Total (n=155) |
Re-visit |
||||
---|---|---|---|---|---|
Group A no (n=95) | Group B yes (n=60) | p value | |||
Age† | 74.0±6.8 | 74.7±7.1 | 73.0±6.4 | 0.13† | |
Sex | |||||
Male | 87 (56.1) | 50 (52.6) | 37 (61.7) | 0.35 | |
Female | 68 (43.9) | 45 (47.4) | 23 (38.3) | ||
Hypertension | 102 (65.8) | 66 (69.5) | 36 (60.0) | 0.30 | |
Diabetes mellitus | 28 (18.1) | 16 (16.8) | 12 (20.0) | 0.78 | |
Cardiovascular | 41 (26.5) | 24 (25.3) | 17 (28.3) | 0.81 | |
Kidney disease | 6 (3.9) | 3 (3.2) | 3 (5.0) | 0.68* | |
Liver disease | 8 (5.2) | 4 (4.2) | 4 (6.7) | 0.71* | |
Neurovascular | 16 (10.3) | 11 (11.6) | 5 (8.3) | 0.71 | |
Hematology | 7 (4.5) | 6 (6.3) | 1 (1.7) | 0.25* | |
Anticoagulants | 18 (11.6) | 6 (6.3) | 12 (20.0) | 0.02 | |
Antiplatelets | 72 (46.5) | 43 (45.3) | 29 (48.3) | 0.84 | |
Thrombolytics | 1 (0.6) | 1 (1.1) | 0 (0.0) | >0.99* | |
Location | |||||
Ant | 111 (71.6) | 74 (77.9) | 37 (61.7) | <0.05 | |
Post | 44 (28.4) | 21 (22.1) | 23 (38.3) | ||
Detail site | |||||
Ant septum | 99 (63.9) | 67 (70.5) | 32 (53.3) | 0.37* | |
Ant IT | 8 (5.2) | 5 (5.3) | 3 (5.0) | ||
Ant IM | 3 (1.9) | 1 (1.1) | 2 (3.3) | ||
Nasal floor | 1 (0.6) | 1 (1.1) | 0 (0.0) | ||
Olfactory cleft | 5 (3.2) | 2 (2.1) | 3 (5.0) | ||
Post septum | 6 (3.9) | 3 (3.2) | 3 (5.0) | ||
Post IM | 1 (0.6) | 0 (0.0) | 1 (1.7) | ||
Nasopharynx | 1 (0.6) | 0 (0.0) | 1 (1.7) | ||
Middle meatus | 4 (2.6) | 2 (2.1) | 2 (3.3) | ||
Unknown | 27 (17.4) | 14 (14.7) | 13 (21.7) | ||
Initial treatment | |||||
Ant packing | 54 (34.8) | 20 (21.1) | 34 (56.7) | <0.001 | |
Post packing | 9 (5.8) | 0 (0.0) | 9 (15.0) | ||
Electrocautery | 50 (32.3) | 40 (42.1) | 10 (16.7) | ||
Observation | 42 (27.1) | 35 (36.8) | 7 (11.7) | ||
ED packing | |||||
No | 115 (74.2) | 84 (88.4) | 31 (51.7) | <0.001 | |
Yes | 40 (25.8) | 11 (11.6) | 29 (48.3) |
Data are presented as the mean±SD or n (%). The average age of all hospitalized patients was 74.0 years, group A was 74.7 and group B was 73.0, and there was no statistically significant difference. There are no significant difference in sex, comorbidities, between group A and B. Location, initially performed anterior packing, ED packing are significant different between group A and B.
p value for Student’s t-test,